Geoffrey C Williams1, Heather Patrick1, Christopher P Niemiec1, L Keoki Williams2, George Divine2, Jennifer Elston Lafata2, Michele Heisler3,4,5, Kaan Tunceli2, Manel Pladevall2. 1. The University of Rochester, Rochester, New York (Dr G. C. Williams, Dr Patrick, Mr Niemiec) 2. Henry Ford Hospital, Detroit, Michigan (Dr L. K. Williams, Dr Divine, Dr Lafata, Dr Tunceli, Dr Pladevall) 3. Veterans Affairs Center for Clinical Practice Management Research, Ann Arbor Health System, Ann Arbor, Michigan (Dr Heisler) 4. Department of Internal Medicine, University of Michigan, Ann Arbor (Dr Heisler) 5. Diabetes Research and Training Center, Ann Arbor, Michigan (Dr Heisler)
Abstract
PURPOSE: The purpose of this study is to apply the self-determination theory (SDT) model of health behavior to predict medication adherence, quality of life, and physiological outcomes among patients with diabetes. METHODS: Patients with diabetes (N = 2973) receiving care from an integrated health care delivery system in 2003 and 2004 were identified from automated databases and invited to participate in this study. In 2005, patients responded to a mixed telephone-and-mail survey assessing perceived autonomy support from health care providers, autonomous self-regulation for medication use, perceived competence for diabetes self-management, medication adherence, and quality of life. In 2006, pharmacy claims data were used to indicate medication adherence, and patients' non-high-density lipoprotein (HDL) cholesterol, A1C, and glucose levels were assessed. RESULTS: The SDT model of health behavior provided adequate fit to the data. As hypothesized, perceived autonomy support from health care providers related positively to autonomous self-regulation for medication use, which in turn related positively to perceived competence for diabetes self-management. Perceived competence then related positively to quality of life and medication adherence, and the latter construct related negatively to non-HDL cholesterol, A1C, and glucose levels. CONCLUSIONS: Health care providers' support for patients' autonomy and competence around medication use and diabetes self-management related positively to medication adherence, quality of life, and physiological outcomes among patients with diabetes.
PURPOSE: The purpose of this study is to apply the self-determination theory (SDT) model of health behavior to predict medication adherence, quality of life, and physiological outcomes among patients with diabetes. METHODS:Patients with diabetes (N = 2973) receiving care from an integrated health care delivery system in 2003 and 2004 were identified from automated databases and invited to participate in this study. In 2005, patients responded to a mixed telephone-and-mail survey assessing perceived autonomy support from health care providers, autonomous self-regulation for medication use, perceived competence for diabetes self-management, medication adherence, and quality of life. In 2006, pharmacy claims data were used to indicate medication adherence, and patients' non-high-density lipoprotein (HDL) cholesterol, A1C, and glucose levels were assessed. RESULTS: The SDT model of health behavior provided adequate fit to the data. As hypothesized, perceived autonomy support from health care providers related positively to autonomous self-regulation for medication use, which in turn related positively to perceived competence for diabetes self-management. Perceived competence then related positively to quality of life and medication adherence, and the latter construct related negatively to non-HDL cholesterol, A1C, and glucose levels. CONCLUSIONS: Health care providers' support for patients' autonomy and competence around medication use and diabetes self-management related positively to medication adherence, quality of life, and physiological outcomes among patients with diabetes.
Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone Journal: Circulation Date: 2004-07-13 Impact factor: 29.690
Authors: Geoffrey C Williams; Holly A McGregor; Allan Zeldman; Zachary R Freedman; Edward L Deci Journal: Health Psychol Date: 2004-01 Impact factor: 4.267
Authors: K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson Journal: JAMA Date: 2003-10-08 Impact factor: 56.272
Authors: Eveline R Goethals; Sarah S Jaser; Chris Verhaak; Sofie Prikken; Kristina Casteels; Koen Luyckx; Alan M Delamater Journal: Diabetes Res Clin Pract Date: 2020-04-20 Impact factor: 5.602
Authors: Ebele M Umeukeje; Joseph R Merighi; Teri Browne; Marcus Wild; Hafez Alsmaan; Kausik Umanath; Julia B Lewis; Kenneth A Wallston; Kerri L Cavanaugh Journal: J Behav Med Date: 2016-05-11
Authors: Elizabeth W Holt; Paul Muntner; C Joyce; Donald E Morisky; Larry S Webber; Marie Krousel-Wood Journal: Am J Epidemiol Date: 2012-10-01 Impact factor: 4.897
Authors: Justin Gatwood; Rajesh Balkrishnan; Steven R Erickson; Lawrence C An; John D Piette; Karen B Farris Journal: Res Social Adm Pharm Date: 2014-02-05
Authors: Lieke G M Raaijmakers; Marloes K Martens; Charlotte Bagchus; Inge de Weerdt; Nanne K de Vries; Stef P J Kremers Journal: J Behav Med Date: 2015-01-29
Authors: Michele Heisler; Timothy P Hofer; Mandi L Klamerus; Julie Schmittdiel; Joe Selby; Mary M Hogan; Hayden B Bosworth; Adam Tremblay; Eve A Kerr Journal: Trials Date: 2010-10-12 Impact factor: 2.279